Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions-Reference-Cited by-同舟云学术

Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions

Published:2017-05-12 Issue:8 Volume:57 Page:2045-2053
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Yoshii Yumi¹,Fujimura Yoshihiro²,Bennett Charles L.³⁴,Isonishi Ayami¹,Kurumatani Norio⁵,Matsumoto Masanori¹

Affiliation:

1. Department of Blood Transfusion Medicine; Nara Medical University; Kashihara Nara Japan

2. Japanese Red Cross Kinki Block Blood Center; Ibaraki Osaka Japan

3. South Carolina Center of Economic Excellence for Medication Safety and Efficacy and the Southern Network on Adverse Reactions (SONAR), South Carolina College of Pharmacy, University of South Carolina; Columbia South Carolina

4. Hollings Cancer Center; the Medical University of South Carolina; Charleston South Carolina

5. Department of Community Health and Epidemiology; Nara Medical University; Kashihara Nara Japan

Funder

Ministry of Health, Labour, and Welfare of Japan

Ministry of Education, Culture, Sports, Science and Technology of Japan

Takeda Science Foundation

National Cancer Institute

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link